|
| Press Releases | | List By Date | Banking/Finance Institutions | Business Law | Corporate | Health Care and Entitlements | Human Resources | Securities | Tax | News Archives | |
For assistance with stories, including interviews with CCH subject experts, please contact
Eric Scott
847-267-2179
eric.scott@wolterskluwer.com |
| |
Contact Information
CCH Offers Essential References on Medicare Part C, Part D Programs
(RIVERWOODS, ILL., March 24, 2005) – The final rules for two programs designed to radically change Medicare, along with expert commentary and useful official documents, have been published in two new books by CCH INCORPORATED (CCH), a leading provider of health law information and software (health.cch.com). Medicare Part C: Medicare Advantage and Medicare Part D: Medicare Prescription Drug Benefit are essential desktop references for any professional who deals with Medicare (324 pages, $79 and 750 pages, $99, respectively).
“It’s clear that many people see the Part C and Part D programs as the wave of the future for Medicare, with private health care and prescription drug providers playing a large role in the program,” said Angela Darrow, product manager for CCH. “Certainly, anyone dealing with Medicare will need a sound understanding of these two programs, and that’s what we provide in these books.”
Medicare Advantage
Medicare Part C: Medicare Advantage is a one-volume publication prepared in response to the Medicare Advantage final rule issued by CMS on January 28, 2005. It contains background, history of the regulations and explanations cross-referenced with the Medicare Part C Final Regulation.
This handy reference contains detailed explanations of the regulations implementing the Medicare Advantage program, the full text of the final rule as it was printed in the Federal Register on January 28, 2005 and 50 pages of appendix material that has several documents from CMS on the Medicare Advantage program. These include frequently asked questions about the Medicare Advantage application process, an introductory letter from the CMS Director of the Medicare Advantage Group, a Memo from the Director of Medicare Advantage regarding transition guidance and several CMS technical issue papers on the Medicare Advantage Program.
Medicare Prescription Drug Benefit
Medicare Part D: Medicare Prescription Drug Benefit is a one-volume publication prepared in response to the Medicare Part D final rule issued by CMS on January 28, 2005. It contains background, history of the regulations and explanations cross-referenced with the Medicare Part D Final Regulation.
This thorough resource contains detailed explanations of the regulations implementing the Prescription Drug Benefit under Part D of the Medicare Program, the full text of the final rule as it was printed in the Federal Register on January 28, 2005 and 150 pages of appendix material with several documents from CMS on the prescription drug benefit. These include draft instructions on completing Medicare prescription drug plan bids for 2006, the application to be a prescription drug provider for 2006, other forms necessary for application to the program and CMS's technical papers on the prescription drug benefit.
Availability and Pricing
For more information or to order either book, call 800-248-3248 or visit the CCH Online Store at health.cch.com/onlinestore. Single-copy price for the 324-page Medicare Part C: Medicare Advantage is $79; single-copy price for the 750-page Medicare Part D: Medicare Prescription Drug Benefit is $99. Quantity discount pricing is available.
About CCH INCORPORATED
CCH INCORPORATED is a leading provider of health care law information and software (health.cch.com). Headquartered in Riverwoods, Ill., CCH was founded in 1913 and has served more than four generations of professionals and their clients. CCH is a Wolters Kluwer company (www.wolterskluwer.com) and, with Aspen Publishers, is part of the Wolters Kluwer Legal unit.
Wolters Kluwer is a leading multinational publisher and information services company. Wolters Kluwer has annual revenues (2004) of €3.3 billion, employs approximately 18,400 people worldwide and maintains operations across Europe, North America and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
-- ### --
EDITOR’S NOTE: Editorial review copies of Medicare Advantage (Part C) 2005 and Medicare Prescription Drug Benefit (Part D) 2005 are available upon request for members of the press. Contact Leslie Bonacum, 847-267-7153 or mediahelp@cch.com or Neil Allen, 847-267-2179 or allenn@cch.com.
nb-05-47
|
|
|
|